FDA Approves Prescription Nasal Spray to Reverse Opioid Overdose

Nalmefene Hydrochloride Product in Nasal Spray Form Provides Additional Tool for Harm Reduction Groups and First Responders SILVER SPRING, Md., May 22, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Opvee, the first nalmefene hydrochloride nasal spray for the…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.